Title |
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
|
---|---|
Published in |
medRxiv, January 2022
|
DOI | 10.1101/2021.12.30.21268540 |
Authors |
Benjamin L. Sievers, Saborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C. Gonzalez, Arianna G. Cassidy, Yarden Golan, Mary Prahl, Stephanie L. Gaw, Prabhu S. Arunachalam, Catherine A. Blish, Scott D. Boyd, Mark M. Davis, Prasanna Jagannathan, Kari C. Nadeau, Bali Pulendran, Upinder Singh, Richard H. Scheuermann, Matthew Frieman, Sanjay Vashee, Taia T. Wang, Gene S. Tan |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 15 | 45% |
Germany | 1 | 3% |
Australia | 1 | 3% |
Poland | 1 | 3% |
India | 1 | 3% |
Israel | 1 | 3% |
Italy | 1 | 3% |
United Kingdom | 1 | 3% |
Unknown | 11 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 22 | 67% |
Scientists | 9 | 27% |
Practitioners (doctors, other healthcare professionals) | 2 | 6% |